Ultimate magazine theme for WordPress.

Systemic Corticosteroids Linked to Poor COVID-19 Outcomes

October 08, 2021

1 minute list

ADD SUBJECT TO EMAIL ALERTS

Receive an email when new articles are published on

Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If this problem persists, please contact [email protected]

Back to Healio

This week, systemic corticosteroid use has been linked to worse Covid-19 results; Investigational Antiviral Medicines Reduce Hospitalization And Death In Patients With COVID-19 By About 50%; Pfizer-BioNTech Submits Vaccine Data for Children Ages 5-11 to FDA; and more.

Read the full coverage here:

Use of systemic corticosteroids has been linked to poorer COVID-19 outcomes

Antiviral reduces the risk of hospitalization and death in patients with COVID-19. by about 50%

Pfizer-BioNTech will submit vaccine data to the FDA for children ages 5-11

Unlike the flu, cold viruses persisted during the pandemic, the study shows

AstraZeneca COVID-19 vaccine 74% effective, protects against asymptomatic diseases

References:

Yochai A, et al. Asthma Treatment: Clinical and Translational Science. Presented at: International Congress of the European Respiratory Society; 5-8 September 2021 (virtual meeting).

Press release

Press release

Rankin, DA, et al. Executive Summary 154. Presented at: IDWeek; September 29th-Oct. 02/03/2021 (virtual meeting).

Sobieszczyk M. et al. Summary LB6. Presented at: IDWeek; September 29th-Oct. 02/03/2021 (virtual meeting).

ADD SUBJECT TO EMAIL ALERTS

Receive an email when new articles are published on

Please enter your email address to receive an email when new articles are published on . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If this problem persists, please contact [email protected]

Back to Healio

Vital capacity

Comments are closed.